Fifty Years of Cell Biology in The Journal of Investigative Dermatology  by O'Keefe, Edward J
Fifty Years of Cell Biology in The Journal of
Investigative Dermatology
Edward J. O’Keefe, M.D.
CELL BIOLOGY
Although the culture of skin in explant culture and the culture of
epidermal keratinocytes comprise the dominant theme in cell biology
described in The Journal of Investigative Dermatology in its 50 years of
publication, only in the last half of that time, since about 1960, have
these studies been numerous. In the last 10 years or less, the utility of the
now established culture methods has enabled the beginning of more
incisive mechanistic studies, which are too varied to describe in a short
essay except in a very limited way. Therefore, I have chosen to trace the
development of methods of culturing epithelium and to select points of
investigations made possible by these methods, and then to note some
studies in cell biology not dependent on culture methods. Many areas of
investigation, such as pigment cell culture, Langerhans cells, immuno-
logic studies, ultrastructure, extracellular matrix, and epidermal kinetics,
have been omitted or are discussed elsewhere in this issue.
Organ Culture of Skin Attempts at cell culture predate organ culture in
studies published in the JID, but organ culture was probably more
widespread in the earlier years. In 1966, Karasek [1] studied epithelial
outgrowth from epidermis in vitro and showed that the process involved
DNA synthesis, not just spreading or migration of the cells. Rothberg [2]
was able to cultivate embryonic chicken skin in a chemically defined
medium and studied the response of the epidermis to vitamin A, which
reduced stratification and synthesis of mucopolysaccharide. Chopra and
Flaxman [3] found that retinoic acid increased labeling index and
growth, but particularly increased the area covered by keratinocyte
explants after an extended period of culture (5 wk).
In 1967, Flaxman et al [4] studied maturation of cells and tissue
organization of epithelial outgrowths from skin explants and noted that
cells attached to plastic were the least differentiated, indicating that the
location of nutrients did not dictate differentiation, as the maturation
gradient was opposite to that predicted on the basis of availability of
nutrients. These authors felt that attachment was important in determin-
ing proliferative potential of epithelial cells. Reaven and Cox [5] cultured
adult human skin in defined medium and studied the effects of tape
stripping on subsequent culture as well as the effects of temperature,
oxygen tension, pH, and serum. Tape stripping was found to produce
increased in vitro labeling after 3–4 d of culture. Bishop and Cox [6]
found that a 10-fold increase in labeled mitoses after the fourth day of
culture followed tape stripping of human skin subsequently studied
in vitro. This remarkable finding, which indicates that skin stimulated by
tape stripping ‘‘remembers’’ the event even after transfer to in vitro
conditions, requires further study. Halprin et al [7] cultured mouse skin
explants in vitro and demonstrated growth and differentiation.
In 1970, Singh and Hardy [8] used a novel method to culture
embryonic rat skin. These authors implanted skin explants in intraper-
itoneal chambers in rats and found that the tissue was still growing after
25 d. Kreider et al [9] transplanted human skin to the hamster cheek
pouch, which had in turn been grafted on the thoracic wall, because they
believed that the cheek pouch was ‘‘immunologically privileged’’ and,
therefore, could tolerate a homograft. Survival of the graft was
demonstrated for 6–8 wk and was more prolonged if the hamster had
been treated with cortisone. Frater and Whitmore [10] were able to
culture newborn mouse follicles in a collagen gel only if a tryptic digest
of mouse embryo extract was present in the medium, even though the
epithelium would grow without such extract. It was of interest that the
embryo extract had to be digested with trypsin to be effective in hair
follicle growth. Frater [11] subsequently demonstrated differentiation of
murine follicular cells in vitro and showed that this occurred only in the
presence of the embryo extract. Flaxman and Harper [12] were able to
culture organ explants of skin for 7 d in defined medium, but DNA
synthesis was observed for only 5 d without serum. Stenn and Stenn [13]
also cultured epithelial explants in defined medium using adult mouse
esophagus, but found that the tissue was viable for only 3 d.
The putative epidermal ‘‘chalone,’’ a concept championed by Elgjo
[14], was studied by Chopra et al [15], among others. Using
autoradiography to assess growth, these authors found that human skin
extracts were inhibitory to the growth of human epidermis in organ
culture even in the absence of epinephrine, which had been thought to
be necessary to demonstrate the effects of the chalone. The chalone
question was also addressed by Rothberg and Arp [16], who demon-
strated inhibition of DNA synthesis by epidermal extracts and no effect of
epinephrine. This complex problem was reviewed by Duell et al [17].
More recently, Elgjo et al [18] have described a purified pentapeptide
with characteristics of the chalone.
The role of cyclic AMP in growth of epithelium in organ culture has
been described in some detail in the Journal. Harper et al [19] sought
differences between psoriatic and normal skin in outgrowth cultures by
perturbing growth with dibutyryl cyclic AMP and other agents affecting
cyclic AMP (epinephrine, isoproterenol, histamine, sodium fluoride, and
theophylline). Agents elevating cyclic AMP inhibited growth but there
was no difference in the results using psoriatic tissue. Kariniemi [20]
cultured psoriatic and normal human skin in diffusion chambers in
intraperitoneal chambers in mice and found no difference in autoradio-
graphic labeling of explants. These findings are in agreement with studies
of cultured cells. Taylor et al [21], in further studies of skin explants,
showed that theophylline and other agents, which inhibit DNA synthesis
at high concentrations, may do so not by stimulating cyclic AMP but by
another, unknown mechanism, as concentrations that were shown to
raise cyclic AMP were not necessarily inhibitory. The action of agents
stimulating cyclic AMP may be complex, because stimulation of cyclic
AMP concentrations is associated with stimulation of proliferation, not
inhibition of growth, in keratinocyte cell culture (see below).
Nieland et al [22] used organ culture to try to investigate the
production in the epithelium of glycogen, which they noted accom-
panied inflammation or injury. Glycogen accumulation in vitro was
stimulated by galactosamine but not by other simple sugars. In 1975,
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Flaxman and Harper [23] studied the in vitro control of keratinocyte
proliferation in explants by various physiologic and pharmacologic
agents, further defining the in vitro behavior of skin in organ culture.
Growth was inhibited by histamine and the inhibitory effect reversed by
antihistamines [24]. Later, Aoyagi et al [25] also found that histamine
inhibited explant growth from pig epidermis, an effect that was prevented
by the more selective antihistamine, cimetidine. Flaxman et al [26] found
that methotrexate was inhibitory to keratinocyte proliferation in vitro, in
contrast with the findings of Liu and Karasek [27] in relatively quiescent
high-density cell cultures, and suggested that de novo synthesis of
nucleotides was probably of significance in the outgrowth cultures. Holt
[28] found that skin organ culture showed enhanced growth in response
to thyroid hormone, triiodothyronine, and thought this probably
represented a direct effect on the epithelium not mediated through the
dermal component. The expression of basement membrane antigens by
organ explants was examined by Didierjean et al [29], who found that
the epithelium as able to elaborate its characteristic antigens even on
dead pig dermis.
Cell Culture of Epidermis In 1957, Wheeler et al [30] described the
development in culture of an apparently transformed human epithelial
cell derived from a biopsy of normal skin. The mechanism of this
phenomenon was not clear. In an early paper on methods of culturing
isolated epidermal cells published in the JID Cruickshank et al [31], in
1960, described the separation of dermis from epidermis in a trypsin
solution, production of an epidermal cell suspension, and plating of these
in high density on a glass surface. This methodology was developed
further by Briggaman et al [32] in a study in which postembryonic human
cells were cultured successfully for longer periods. In 1970, Laerum and
Boyum [33] developed a method for separation of basal cells from more
differentiated keratinocytes and cultured basal cells from hairless mouse
epidermis intraperitoneally in plastic chambers, in which the cells were
isolated from the environment by Millipore filters. In 1970, Yuspa et al
[34] reported the growth of fetal mouse keratinocytes in culture for 4–5 d
and subsequent replating as a single cell preparation in chambers on the
backs of mice. These grafted cells contained both fibroblasts and
keratinocytes, and the grafts produced follicles and hair and also
pigment. The production of follicles in the skin presumably depended
on the fetal nature of the transplanted cells.
Karasek and Charlton [35] subsequently reported the growth of
postembryonic skin epithelial cells using collagen gels. Growth was
improved by the collagen and also by conditioned medium. Moore and
Karasek [36] used the method of Laerum and Boyum [33] to separate
basal and differentiated cells and successfully cultivated postembryonic
epithelium from mouse, rabbit, and human. They found that cells that
attach to collagen were the germinative population; that is, were capable
of synthesizing DNA and protein. These cells could be discriminated by
their characteristically high ratio of nucleus to cytoplasm. Vaughan and
Bernstein [37] also believed that trypsinized rat skin released basal cells
first when epidermis was agitated in solution, as these were the cells that
incorporated thymidine in culture. Fusenig and Worst [38] described
prolonged culture of adult mouse epidermal cells for the first time and
showed minimal contamination by fibroblasts.
The introduction of specific growth factors enhanced the success of
culture and permitted mechanistic studies. In 1963, Cohen and Elliott
[39] described the action of a purified protein from the sub-maxillary
gland of the mouse, which was capable of eliciting precocious separation
of the eyelids, a phenomenon that depended on the keratinization of the
two opposing lids (Fig 1), and also the premature eruption of teeth in
newborn mice. A subsequent review noted that because the factor,
known as epidermal growth factor (EGF), could stimulate the growth of
isolated embryonic epithelium and corneal epithelium, it was clearly
acting not through the dermis but on epidermal cells [40]. Another agent,
retinoic acid, was found by Christophers [41] to be useful in the culture
of guinea pig epidermal cells. In cells grown with McCoy’s medium and
10% fetal calf serum, retinoic acid appeared to increase attachment of
cells and enhanced DNA synthesis, apparently in agreement with the
previously noted in vivo stimulation associated with topical application
or oral administration in vitamin A-deficient animals as described by
Sherman [42]. Stimulation of growth in vitro by retinoids has previously
been described in skin organ culture [3], but was recently shown by Tong
et al [43] to occur in cell culture if the appropriate limiting conditions can
be found.
Inclusion of proceedings of the annual symposia on the biology of
skin has provided important reviews of various areas of skin biology in
the Journal. In the July 1975 issue, entitled ‘‘The Epidermis,’’ Karasek
reviewed the growth and maturation of epithelial cells in vitro from
postembryonic skin. Liu and Karasek [27] later reported improvements in
epithelial cell culture in an important study. They plated rabbit
keratinocytes at high density and found that negligible DNA synthesis
occurred in the primary culture; they were then able to passage the cells,
at which time they demonstrated an increase in cell number and
thymidine incorporation and associated sensitivity to methotrexate not
demonstrable in the primary culture. These investigators also reported
that both collagen gels and L-serine enhanced proliferative growth. A
subsequent paper [44] further described the use of collagen gels,
L-serine, and corticosteroids in cultures. L-serine (0.4mM) and
dexamethasone (1 mg/ml) were stimulatory to growth in these cultures
of human epidermal keratinocytes. Also in 1978, Carpenter described
what had been learned about EGF in the 15 years since its discovery in an
important review. Elsewhere, Rheinwald and Green described the clonal
growth of keratinocytes on 3T3 feeder layers [45] and also showed that
the keratinocytes proliferated in response to EGF [46] (Fig 2). In a
variation of the method of Rheinwald and Green, Kondo et al [47]
described the growth of human epidermal cells on 3T3 feeder layers
using Millipore filters to facilitate examination of epithelial growth
in vitro.
In attempts to examine the biology of cultured keratinocytes,
Gilchrest [48] studied actinically damaged or protected skin and found
that keratinocytes from protected skin produced more generations in vitro
and that a reduction in generations was proportional to the severity of the
actinic damage and the age of the donor. It was found that plating
efficiency was substantially higher for the damaged skin. This was
thought possibly to reflect the promoting activity of the actinic damage,
which may have increased the proliferative activity of the basal cell
population, while at the same time shortening the apparent longevity of
the keratinocytes because of their advanced apparent senescence. In
1979, Prunieras [49] reviewed the field of cell culture with particular
emphasis on the problem of the study of morphogenesis using tissue
culture and commented on the eventual possibility of exploring the
interaction of keratinocytes with other cultured cells such as Langerhans
cells or melanocytes.
In 1980, Stanley et al [50] extended the experiments of Moore and
Karasek [36]. Studying the cells that attach to collagen, which had earlier
Figure 1. Cross sections of the eyelid area from control (a) and experimental
(b) 8-d-old rats. The experimental animal had received daily injections (1 mg/g
body weight) of the active protein. (100.) From Cohen and Elliott [39].
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been found to be the germinative population, these investigators found
that such cells could also be identified by their content of pemphigoid
antigen and the absence of an upper cytoplasmic antigen, confirming that
the cells that adhere to collagen were basal cells.
In 1980, Hawley-Nelson et al [51] described a method for the culture
of human epidermal cells that permitted subculture 2–3 times and used
reduced calcium concentrations, which these investigators had pre-
viously found to prevent stratification of mouse keratinocytes. A collagen
substrate was also found to enhance growth in this culture system.
Because calcium stimulates differentiation, a calcium signal could also
be used to detect malignant or possibly premalignant cells altered by
carcinogens, as these cells responded poorly to calcium and did not
terminally differentiate and cease to proliferate (Fig 3); this finding has
provided an important in vitro correlate of carcinogenesis [52].
In another example of the utility epidermal cell culture in elucidating
mechanisms, Yaar et al [53] found that retinoic acid decreased the
terminal differentiation of keratinocytes, as assessed by measurement of
the production of envelopes and cross-linked keratin,with maximal
effects at 0.5–5 mg/ml. Milstone et al [54] found that retinoic acid caused
premature desquamation of cells from confluent cultures of keratino-
cytes. Furthermore, the desquamated cells had a reduced ratio of protein
to DNA, indicating that they were less fully differentiated in the presence
of retinoic acid. Differences were found between calf esophagus and
human foreskin keratinocytes. Retinoic acid decreased proliferation of
the calf cells. In the case of human foreskin cells, which showed a
reduced proliferation after weeks in culture in control cultures, the
decrease was reduced in the presence of retinoic acid (3.3mM). The
thickness of the culture and the numbers of cell layers were reduced by
retinoic acid in both types of cultures.
The action of vitamin D on cultured keratinocytes has been reported
in the Journal. Smith et al [55] grew keratinocytes in serum-free
conditions and demonstrated a dose-dependent decrease in basal cells,
an increase in desquamating cells, and inhibition of DNA synthesis by
the active form of vitamin D, 1,25-dihydroxy vitamin D3, and suggested
that this hormone may play a role in differentiation and development.
These investigators also showed that the action of vitamin D was related
to the concentration of the receptor in the skin [56].
Immunologic studies began to be directed at keratinocyte cultures. In
1982, Morhenn et al [57] showed that cultured human epidermal cells
did not have characteristics of Langerhans cells by rosetting of
erythrocytes or electron microscopy, suggesting that the Langerhans
cells were lost during culture. They also proposed a method for the
culture of keratinocytes on a gelatin membrane without plastic. An
immunologic function was ascribed to epidermal cells after Sauder et al
[58] demonstrated the production of epidermal thymocyte activating
factor (ETAF) in keratinocyte cultures. Luger et al [59] also found that an
interleukin l(IL-l)-like factor was produced by cultured keratinocytes. The
material in their supernatants increased IL-2 production by human
peripheral blood lymphocytes in the presence of concanavalin A
(Con-A), was mitogenic for fibroblasts, was chemotactic for neutrophils,
and increased serum amyloid A production by murine hepatocytes. The
ETAF activity was increased by sublethal doses of ultraviolet light [60]
both in vitro and in vivo, a finding with major implications for cutaneous
biology (Fig 4). Kupper and McGuire [61] found that micromolar
concentrations of hydrocortisone suppressed production of ETAF. Goslen
et al [62] found that extracts of basal cell carcinomas could stimulate
collagenase production from fibroblasts and suggested that these extracts
might contain ETAF or other IL-l-like material. Interleukin-1 had been
shown elsewhere to enhance collagenase production by fibroblasts.
Hernandez et al [63] established basal cell carcinoma cells in culture and
found that supernatants from these cultures increased collagenase
production. The supernatants also increased thymocyte proliferation,
which indicated that they contained an IL-1-like material. These authors
suggested that the basal cells demonstrated aberrant release of the
mediator of this kind of activity. Evidence was also presented by
Woodley et al [64] that keratinocytes were able to produce collageno-
lytic activity against collagen types I and IV, a finding that led to the
demonstration by Petersen et al [65] of the production of collagenase by
keratinocyte cultures. Interleukin-1 did not stimulate collagenase in
keratinocytes.
A novel phenomenon in keratinocyte cultures reported by Ristow [66]
was the partial arrest of growth of mouse epidermal keratinocytes by
treatment with serum-free medium containing 0.06mM calcium for 4 d.
Peripheral blood leukocytes were shown to stimulate such cultures to
incorporate tritiated thymidine and label a substantial proportion of their
nuclei. More recently, Ristow [67] has reported elsewhere the stimulation
of growth of keratinocytes byIL-1.
At a time of major interest in the role of cyclic AMP in cellular
growth, several laboratories published studies of the possible role of
Figure 2. Effect of EGF on growth of keratinocytes. Numbers indicate ng/ml of
EGF. From Rheinwald and Green [46].
Figure 3. Effect of calcium switch on DNA synthesis. Primary keratinocytes or
cells from lines 308, D, and F were each grown to confluence in medium with
0.05mM calcium, then switched to medium with 1.2mM calcium. [3H]
Thymidine (1 mCi/ml) was added 23 h after the calcium switch, and cells were
harvested at 24 h. The specific activity of DNA (cpm/mg DNA) was
determined as a measure of the rate of DNA synthesis. Values in low-calcium
medium are indicated by the open bars; values in high-calcium are shown by
the solid bars. From Hawley-Nelson et al [51].
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cyclic nucleotides in keratinocyte growth in the JID. Wilkinson et al [68]
found that cyclic AMP concentrations varied with the cell cycle in
keratinocytes; concentrations were low in G1 and high in cells with high
DNA content (G2) as shown by flow cytometry. S-phase could not be
assessed specificially. Effects of cyclic AMP were also studied by Okada
et al [69], who found that cholera toxin produced 100-fold increases in
cyclic AMP but was effective in increasing growth of keratinocytes, as
has been demonstrated elsewhere by Green [70], only in subconfluent
cells in cultures. The cultures of Okada et al were plated in high calcium
in the presence of serum. In other studies related to cyclic AMP,
Orenberg et al [71] reviewed findings for adrenergic receptors in cultured
epidermal keratinocytes, which are sensitive to catecholamines, hista-
mine, adenosine, and PGE1 and PGE2 and found that the keratinocyte
receptor behaved like a beta2 receptor. This conclusion was based on
intracellular cyclic AMP concentrations after incubation for 2 h in the
presence of a phosphodiesterase inhibitor.
Other types of receptors have also been studied in keratinocytes in
culture. O’Keefe et al [72] demonstrated the presence of EGF receptors in
cultured keratinocytes and showed that the binding of EGF was
dramatically increased by reduction of calcium ion, a condition that
favored keratinocyte growth [73]. Fleckman et al [74] found that EGF
stimulated ornithine decarboxylase activity in keratinocyte cultures.
Baden and Kubilus [75] reported production of rat keratinocyte lines from
cultures of newborn rat keratinocytes grown in the absence of EGF. These
cells were able to grow without 3T3 cells and were polyploid but would
not grow in soft agar and had desmosomes, cell envelopes, and
keratohyalin granules. Misra et al [76] demonstrated the binding of
insulinlike growth factor I/somatomedin-C in human keratinocytes in
culture.
Isseroff et al [77] demonstrated the presence of plasminogen activator
in differentiating mouse keratinocytes and found that activity was highest
in shed cells and increased at confluence. The plasminogen activator
activity peaked as DNA synthesis declined. Subsequently, these authors
[78] found that plasminogen was demonstrable in the basal layer of the
epidermis when antiplasminogen antibody was used to stain the
epidermis. An instructive point in this paper was the requirement for
the demonstration of plasminogen for affinity-purified antibody to reduce
background. The authors proposed that this demonstration provided
evidence that plasmin, generated by epidermal plasminogen activator
from plasminogen, may have a role in epidermal differentiation.
Furthermore, the location of plasminogen in the basal layer suggested
that it may be consumed during the course of differentiation. Hashimoto
et al [79] also demonstrated plasminogen activator in cultured
keratinocytes and showed that conditioned medium could cleave fibrin.
The activity was stimulated by cholera toxin or EGF. Morioka et al [80]
found that migrating keratinocytes express urokinase-type plasminogen
activator at the migrating edge of a wound. They proposed that the
enzyme may cleave fibronectin and that such cleavage may be necessary
for migration of cells.
Although there was great hope that the use of cell culture would
permit the identification of in vitro correlates for the psoriatic phenotype,
Baden et al [81] found no differences in growth characteristics of normal
and psoriatic keratinocytes alone or of keratinocytes grown with psoriatic
or normal fibroblasts as a feeder layer. Liu and Parsons [82] found no
difference in growth rate, cell detachment from culture, metabolic
labeling with leucine or thymidine, or mitotic cells between psoriatic and
normal keratinocytes in an extensive in vitro study.
Keratinocyte cultures have also been used to study the effects of
drugs. A provocative effect demonstrated by Baden and Kubilus [83] was
the ability of minoxidil at 70mg/ml to increase the apparent survival of
cultures of keratinocytes, appearing to slow their senescence, a
characteristic in common with EGF. The time after which cells could
be passaged after confluence was increased by either minoxidil or EGF.
Cohen et al [84] also found a possible stimulation of growth of mouse
keratinocytes by minoxidil at concentrations of 5–20mg/ml. Cyclosporin
A, generally thought to improve psoriasis through its action on
lymphocytes, was shown to inhibit keratinocyte growth in vitro at
clinically relevant concentrations [85,86].
An important enhancement in the ability to culture keratinocytes was
devised by Boyce and Ham [87], who developed a chemically defined
medium capable of supporting clonal culture of keratinocytes. Although
technically more difficult to perform than culture as described by
Rheinwald and Green with a 3T3 feeder layer, this unique method
permitted culture in the absence of serum. This and other papers
appeared in a 1983 supplement to the JID entitled ‘‘The Biology of the
Keratinocyte In Vitro,’’ which provided useful reviews of many aspects of
keratinocyte biology including involucrin, filaggrin, keratin classes,
envelope production, action of retinoids, and the question of epidermal
stem cells.
In the last several years, many different mechanisms have been
studied in keratinocyte cultures as the utility of these cultures has
increased and more investigators have studied keratinocyte biology
in vitro. Albers and Taichman [88] devised an ingenious method to
determine what proportion of keratinocytes in culture continued to
divide and presented evidence that only about 77% of dividing cells
continue to divide in a subsequent cell cycle, thus providing a direct
measurement of the rate of loss of cells from the proliferative
compartment in vitro. The ability of retinoic acid to affect pemphigus
and pemphigoid antigens was studied by Thivolet et al [89], who found
that retinoic acid affected differentiation but did not always affect specific
antigens in the expected way. For example, although retinoic acid could
decrease certain differentiation markers, such as keratohyalin granules or
the 67-kD keratin, it increased apparent amounts of pemphigus antigen,
as demonstrated by immunofluorescence. On the other hand, if calcium
was raised, increasing these differentiated functions, pemphigus antigen
was also increased in that setting. In vitamin A-deficient serum, when
cultures were well differentiated pemphigus antigen was depleted. The
authors concluded that because of these complex findings pemphigus
antigen is not a good marker of differentiation of keratinocyte cultures.
Milstone and LaVigne [90] demonstrated for the first time that TCDD,
which causes epidermal hyperplasia in animals and chloracne in
humans, produced hyperplasia in pure cultures of keratinocytes,
increasing cells, protein, and thymidine incorporation. The concern has
Figure 4. Effect of in vitro UV on the intracellular (J—J) and extracellular
(K—K) production of ETAF activity by the squamous cell carcinoma line
(SSC). From Ansel et al [60].
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arisen that studies of thymidine incorporation in epidermal cell culture
may give rise to artifacts. Milstone and LaVigne [91] investigated the
reason for nonrandom distribution of labeled nuclei when keratinocytes
were incubated with tritiated thymidine. This had been thought to be a
technical artifact, possibly based on the inability of thymidine to diffuse
through stratified layers of cornified cells. The results indicated clearly
that such labeling was not artifactual but was a characteristic of the
cultures.
The production of fibronectin by keratinocytes [92,93], the attach-
ment [94], spreading [95], and migration [96] of keratinocytes on
fibronectin, and the expression of fibronectin receptor function [95] have
provided a foundation for the idea, described in some detail in JID
articles, that fibronectin may provide one of the earliest adhesion factors
for keratinocytes migrating over a wound, before the production of other
matrix factors and the subsequent organization of the basement
membrane. Fibronectin in the region of the basement membrane can
indeed be contributed by the epithelium [97] or by basal cell carcinoma
cells [98]. Fibronectin messenger-RNA was recently demonstrated in
keratinocytes [99] and enhanced production of keratinocyte fibronectin
was demonstrated in response to transforming growth factor-beta [100].
A block in the ability of keratinocytes to spread occurs in vitro when the
cells reach confluence and is removed after several days of subculture at
sub-confluent concentrations [101]. Similar failure to spread occurs
in vivo, as newly plated keratinocytes from skin spread poorly, and this
similarly improves after culture for several days, at a time when the cells
begin to recognize fibronectin [102]. Because cells in healing epithelium
are required to spread and migrate, fibronectin receptor function is
emerging as a critical feature of wound healing. The actions of a plasma-
derived spreading factor, epibolin, have been described by Stenn et al
[103], who presented evidence that protein kinase C may be involved in
epibolin-mediated spreading. Negi et al [104] described cell detachment,
more marked in the presence of complement, produced by a monoclonal
antibody to a 35-kD cell surface protein.
In the last decade cell culture has been used for a large number of
different types of studies, some of which are described in other sections
of this volume. Pigment cell studies, the culture of melanocytes, and the
production of extracellular matrix proteins have been described.
Other Studies in Cell Biology Other studies in cell biology are too
varied to group either by subject or by methodology in this short
summary but have used subcellular fractions from skm, intact skin,
fibroblasts or other types of cells, or intact animals.
Eye-derived growth factor was shown to reduce epithelial resurfacing
time in skin wounds [105]. Basic fibroblast growth factor, which is, like
eye-derived growth factor, a member of the family of heparin-binding
growth factors, was shown to stimulate growth of keratinocytes [106].
Epidermal growth factor was shown to slow hair growth and more
remarkably, rapidly to induce catagen’ in sheep, facilitating a ‘‘chemi-
cal’’ shearing [107,108]. Lord and Ziboh [109] demonstrated binding of
prostaglandin E2 to membranes from human skin and inhibition of this
binding by ultraviolet B irradiation. The action of corticosteroids was
examined by Runikis et al [110], who noted an increased growth of
cultured human fibroblasts by glucocorticoids, a different finding from
that in mouse cells, which were inhibited. Ponec et al [111]
demonstrated specific binding of corticosteroids to human skin fibroblast
receptors and related their findings to potency of growth inhibition. The
glucocorticoid receptor in human skin cytosol was characterized in some
detail by Leiferman et al [112]. Ponec et al [113] correlated binding of
corticosteroids with clinical efficacy. Sarnstrand et al [114] found a
reduction of glycosaminoglycan metabolism in fibroblasts in response to
corticosteroids, which was thought possibly to reflect atrophogenic
changes.
Epidermal growth factor receptors were visualized in epidermis by
Nanney et al [115] and in epidermal appendages as well. The binding
was substantially altered in psoriasis [116]; binding was detected not
only in the basal cell layer but also in upper layers of the epidermis.
Green and Couchman [117] also found EGF receptors in epithelium
using similar autoradiographic and antireceptor antibody staining
techniques. Green and Couchman [118] subsequently confirmed the
finding of Nanney et al [115] that binding detected by 125I-labeled EGF
was less extensive than demonstration of receptor by antireceptor
antibody, indicating that receptor was present that could not bind EGF.
The significance of such occult receptors is uncertain.
Bullous pemphigoid antigen, long thought to be a base-
ment membrane antigen, may be primarily intracellular. Several
studies indicate that the antigen is better demonstrated in permeabilized
cells and may be associated with hemidesmosomes (Fig 5) [119–121].
In other recent studies, chemotaxis of keratinocytes was demon-
strated, and chemoattraction was marked in response to IL-1 or
conditioned medium from cultured smooth muscle cells [122]. Also,
Madison et al [123] developed conditions for expression of lamellar
granules in vitro.
This review demonstrates a remarkable change in the quality and
breadth of studies in cell biology published in the JID. These studies and
others described in this issue show the continual development of the JID
with contributions of more scientifically rigorous work and broader scope
into a major repository of studies in cutaneous biology. The incorporation
and reporting of developments in culture methods has been the major
area of this change, as this has been a requisite for many studies of cyclic
AMP and growth, growth factors, receptors, wound healing, mechanism
of action of drugs at a cellular level, and others. Although culture
methods as such and the effects of various agents on culture itself were
emphasized initially, current studies more often involve biologic or
biochemical mechanisms elucidated in culture.
The increasing scope and sophistication of these studies bodes well
for future work if the momentum can be maintained. The JID is the
appropriate vehicle for representation in cutaneous biology of the
ongoing revolution in biologic science. We can, therefore, expect to see
more molecular and biochemical studies in the near future and the
continuing emergence of the JID as a major means of communication,
and not only publication, for investigators in cutaneous biology.
Figure 5. Binding of bullous pemphigoid antibodies by trypsin-dissociated
epidermal basal cells. This panel shows basal cells in suspension pretreated
with saponin before incubation with BP serum and fluorescent conjugate.
Under these conditions all basal cells bound BP antibody, producing a diffuse
granular pattern of fluorescence. From Mutasim et al [120].
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